Kevin Hykes is an Operating Partner at Versant Ventures and CEO of Metavention, Inc., an early-stage medical device company focused on the development of interventional therapies for the treatment of type 2 diabetes.
Kevin was previously President and Chief Executive Officer of Cameron Health, developer of the first and only subcutaneous implantable defibrillator, until its acquisition by Boston Scientific in 2012. Prior to Cameron, he was the Chief Commercial Officer of Visiogen, Inc., a venture-backed ophthalmology company which was acquired by Abbott Medical Optics in October of 2009. Previous to Visiogen, he spent sixteen years at Medtronic, where he held leadership positions in the CRM, Neurological, Heart Valve, and Cardiac Surgery businesses in the US and Europe.
Kevin received his MBA from Northwestern University and a BBA in Information Systems from the University of Wisconsin, and is an independent director of Hansen Medical, Inc (HNSN).